Literature DB >> 2448361

Effect of ketotifen on human alveolar macrophages.

Y Kakuta1, T Kato, H Sasaki, T Takishima.   

Abstract

In order to examine the possibility of human alveolar macrophages being an effector site of an antiasthmatic drug, we studied the effect of ketotifen on chemiluminescence and Ca-activated K conductance at single channel level because they are associated with the activation of macrophages. Peak chemiluminescence response, induced by a single concentration of phorbol myristate acetate (0.5 micrograms/ml), was inhibited by 28 +/- 3, 51 +/- 8, and 76 +/- 7% by ketotifen concentrations of 0.02, 0.12, and 0.24 mmol/L, respectively. The inhibition of chemiluminescence by ketotifen concentrations of 0.12 and 0.24 mmol/L was also observed in macrophages stimulated with zymosan activated serum (54 +/- 7 and 80 +/- 6%, respectively). Moreover, ketotifen, 0.24 mmol/L, inhibited Ca-activated K channel currents by 44 +/- 7% (large currents) and 48 +/- 13% (small currents). These results may explain, at least partly, antiasthmatic effects of ketotifen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448361     DOI: 10.1016/0091-6749(88)90919-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

Review 1.  Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.

Authors:  S M Grant; K L Goa; A Fitton; E M Sorkin
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

2.  Effects of ketotifen on airway responses to allergen challenge in the actively sensitized brown Norway rat.

Authors:  S Sapienza; P M Renzi; J G Martin
Journal:  Agents Actions       Date:  1992-11

3.  Mast cells play no role in the pathogenesis of postoperative ileus induced by intestinal manipulation.

Authors:  Pedro J Gomez-Pinilla; Giovanna Farro; Martina Di Giovangiulio; Nathalie Stakenborg; Andrea Némethova; Annick de Vries; Adrian Liston; Thorsten B Feyerabend; Hans-Reimer Rodewald; Hans-Reimwer Rodewald; Guy E Boeckxstaens; Gianluca Matteoli
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.